Expenditures for specialty drugs account for more than 25 percent of total US drug spending
and have been increasing at more than 13 percent annually. We examined insurers' role in …

In recent years various governments, pharmacy associations, consumer groups and the
pharmaceutical industry have suggested that more drugs should be switched from …

We analyze whether the possibility for physicians to dispense drugs increases health care
expenditures due to the incentives created by the markup on drugs sold. Using …

Pressure to control pharmaceutical expenditure and price competition among
pharmaceutical companies are fuelling the development of generic drug markets in EU …

Objective: To decompose pharmaceutical spending growth into price and quantity
components and to compare growth across different types of health plans Study Design …

We use a data set which contains information on a nationally representative sample of drug
purchases in 1996 to investigate the relationship between the type of insurance individuals …

Background Publicly-funded drug plans vary in strategies used and policies employed to
reduce continually increasing pharmaceutical expenditures. We systematically reviewed the …

The aim of this paper is to empirically analyse the responses by general practitioners to
promotional activities for ethical drugs by pharmaceutical companies. Promotion can be …

We develop an analytic framework to map out the nature and relative importance of different
cost-driving trends in the prescription drug market. This is used to measure prescription drug …

In this paper empirical evidence for substitution processes caused by the budget for drugs
prescribed by office-based physicians is provided. Due to substitution processes in a natural …